ResMed announced that it secured a victory in a patent battle with New York University. The San Diego-based respiratory device maker said the U.S. Patent Trial and Appeals Board (PTAB) invalidated NYU claims against ResMed. These claims came based on seven NYU patents. In June 2021, NYU filed a complaint for patent infringement against ResMed […]
Patent Trial and Appeal Board (PTAB)
Axonics loses IP challenge to Medtronic patents
Medtronic (NYSE:MDT) announced that it picked up three victories in an intellectual property (IP) dispute against Axonics (NSDQ:AXNX) over sacral neuromodulation devices. According to a news release, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) rejected Axonics’ attempt to invalidate three Medtronic patents in its IP infringement lawsuit related to Medtronic’s […]
U.S. Supreme Court kicks Arthrex case back to patent board
The U.S. Supreme Court ruled today that Patent Trial and Appeal Board judges are unconstitutionally appointed, but that greater supervision by the PTAB director would solve the problem. The opinion in the case followed a 2019 appeals court ruling in the closely watched patent spat between Arthrex and Smith+Nephew (NYSE:SNN). In the original lawsuit, Smith+Nephew and ArthroCare (which Smith+Nephew acquired in 2014) petitioned […]
3 things medical device companies should know about the Patent Trial and Appeal Board
With nearly a decade of proceedings behind it, the Patent Trial and Appeal Board (PTAB) has established a record. Medtech companies can learn from it. Timothy P. McAnulty and Daniel F. Klodowski, Finnegan One of the key aspects of a strong patent is the owner’s ability to enforce it. And when a patent is asserted […]